Cargando…

Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation

BACKGROUND: This study examined whether defects in insulin secretion contribute to the development and progression of type 2 diabetes mellitus (T2DM). METHODS: Plasma insulin and glucose were measured after a glucose tolerance test to calculate the insulinogenic index (IGI) and the HOMA-IR Homeostas...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Sang Youl, Kwon, Mi Kwang, Park, Byong-Jo, Chon, Suk, Jeong, In-Kyung, Oh, Seungjoon, Ahn, Kyu Jeung, Chung, Ho Yeon, Kim, Sung Woon, Kim, Jin-Woo, Kim, Young Seol, Woo, Jeong-taek
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687668/
https://www.ncbi.nlm.nih.gov/pubmed/18309686
http://dx.doi.org/10.3904/kjim.2007.22.4.270
_version_ 1782167565411287040
author Rhee, Sang Youl
Kwon, Mi Kwang
Park, Byong-Jo
Chon, Suk
Jeong, In-Kyung
Oh, Seungjoon
Ahn, Kyu Jeung
Chung, Ho Yeon
Kim, Sung Woon
Kim, Jin-Woo
Kim, Young Seol
Woo, Jeong-taek
author_facet Rhee, Sang Youl
Kwon, Mi Kwang
Park, Byong-Jo
Chon, Suk
Jeong, In-Kyung
Oh, Seungjoon
Ahn, Kyu Jeung
Chung, Ho Yeon
Kim, Sung Woon
Kim, Jin-Woo
Kim, Young Seol
Woo, Jeong-taek
author_sort Rhee, Sang Youl
collection PubMed
description BACKGROUND: This study examined whether defects in insulin secretion contribute to the development and progression of type 2 diabetes mellitus (T2DM). METHODS: Plasma insulin and glucose were measured after a glucose tolerance test to calculate the insulinogenic index (IGI) and the HOMA-IR Homeostasis model assessment of insulin resistance in subjects with normal glucose tolerance (NGT), prediabetes (preDM, n=49), and T2DM patients with disease duration <1 year (n=84), 1~5 years (n=45), or >5 years (n=37). Plasma proinsulin and adiponectin levels were also measured as a parameter of insulin secretion and resistance. RESULTS: The mean HOMA-IR increased and the adiponectin levels decreased relative to the deterioration of glucose tolerance in NGT and preDM subjects. However, differences in the HOMA-IR were not related to disease duration in T2DM subjects. The mean IGI was similar in NGT and preDM subjects, but there were significant deteriorations in IGI relative to the duration of diabetes. CONCLUSIONS: Defects in both insulin sensitivity and insulin secretion contribute to T2DM, but decreased insulin secretion may be more important in the development and progression of T2DM.
format Text
id pubmed-2687668
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-26876682009-06-15 Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation Rhee, Sang Youl Kwon, Mi Kwang Park, Byong-Jo Chon, Suk Jeong, In-Kyung Oh, Seungjoon Ahn, Kyu Jeung Chung, Ho Yeon Kim, Sung Woon Kim, Jin-Woo Kim, Young Seol Woo, Jeong-taek Korean J Intern Med Original Article BACKGROUND: This study examined whether defects in insulin secretion contribute to the development and progression of type 2 diabetes mellitus (T2DM). METHODS: Plasma insulin and glucose were measured after a glucose tolerance test to calculate the insulinogenic index (IGI) and the HOMA-IR Homeostasis model assessment of insulin resistance in subjects with normal glucose tolerance (NGT), prediabetes (preDM, n=49), and T2DM patients with disease duration <1 year (n=84), 1~5 years (n=45), or >5 years (n=37). Plasma proinsulin and adiponectin levels were also measured as a parameter of insulin secretion and resistance. RESULTS: The mean HOMA-IR increased and the adiponectin levels decreased relative to the deterioration of glucose tolerance in NGT and preDM subjects. However, differences in the HOMA-IR were not related to disease duration in T2DM subjects. The mean IGI was similar in NGT and preDM subjects, but there were significant deteriorations in IGI relative to the duration of diabetes. CONCLUSIONS: Defects in both insulin sensitivity and insulin secretion contribute to T2DM, but decreased insulin secretion may be more important in the development and progression of T2DM. The Korean Association of Internal Medicine 2007-12 2007-12-20 /pmc/articles/PMC2687668/ /pubmed/18309686 http://dx.doi.org/10.3904/kjim.2007.22.4.270 Text en Copyright © 2007 The Korean Association of Internal Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rhee, Sang Youl
Kwon, Mi Kwang
Park, Byong-Jo
Chon, Suk
Jeong, In-Kyung
Oh, Seungjoon
Ahn, Kyu Jeung
Chung, Ho Yeon
Kim, Sung Woon
Kim, Jin-Woo
Kim, Young Seol
Woo, Jeong-taek
Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title_full Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title_fullStr Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title_full_unstemmed Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title_short Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
title_sort differences in insulin sensitivity and secretory capacity based on ogtt in subjects with impaired glucose regulation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687668/
https://www.ncbi.nlm.nih.gov/pubmed/18309686
http://dx.doi.org/10.3904/kjim.2007.22.4.270
work_keys_str_mv AT rheesangyoul differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT kwonmikwang differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT parkbyongjo differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT chonsuk differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT jeonginkyung differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT ohseungjoon differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT ahnkyujeung differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT chunghoyeon differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT kimsungwoon differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT kimjinwoo differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT kimyoungseol differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation
AT woojeongtaek differencesininsulinsensitivityandsecretorycapacitybasedonogttinsubjectswithimpairedglucoseregulation